Conference Addresses How the Microbiome Impacts Health and Wellness
It was a full house at the Microbiome Conference at 7 Dana Road on June 12 when clinical, basic research and industry experts shared their work on microbiome science and its role in maintaining health and causing a gamut of disease.
The half-day symposium featured remarks by College leadership including Alan Kadish, M.D., president, Edward C. Halperin, M.D., M.A., chancellor and chief executive officer, and Jerry L. Nadler, M.D., MACP, FAHA, FACE, dean of the School of Medicine. Guest speakers covered the topics of fecal transplants, the role of bacterial metacolony in chronic tonsillar hypertrophy, meta genomic and metatranscriptomic profiling of mouse gut microbiota, intestinal microbiomes in sickle cell disease and population studies of gut microbiome, diet and human health.
“I am very pleased to see New York Medical College and the Touro College and University System becoming a player in the rapidly expanding and important arena of microbiome research and the way we think about pathogenesis of disease. I am hopeful that such events will help jump start our biomedical research programs and stimulate transdisciplinary research via strategic partnerships,” said Salomon Amar, D.D.S., Ph.D., vice president of research at NYMC and provost for biomedical research and chief biomedical research officer for Touro College and University System, who served as the conference chair.
The conference was co-sponsored by Viome and BioInc@NYMC.
